Research ArticleInternational Journal of Pharmaceutical InvestigationVol. 16 | Issue 1 | 2026 | pp. 283–289Open access
Comparative Analysis of Functional Capacity Improvements Through 6MWD Testing Across Different Respiratory Conditions: Implications for Targeted Pulmonary Rehabilitation
- 1*,
- 1
- 1 Department of Pharmacology L. M. College of Pharmacy, Ahmedabad, Gujarat, INDIA, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Sneha Chacko
Department of Pharmacology L. M. College of Pharmacy, Ahmedabad, Gujarat, INDIA, INDIA.
Email: saumyasneha@gmail.com
Copyright: © 2026 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2026
- Received:
- May 9, 2025
- Accepted:
- Sep 12, 2025
- DOI:
- 10.5530/ijpi.20260451
How to cite
Chacko, S., & Shah, G. (2026). Comparative Analysis of Functional Capacity Improvements Through 6MWD Testing Across Different Respiratory Conditions: Implications for Targeted Pulmonary Rehabilitation. International Journal of Pharmaceutical Investigation, 16(1), 283–289. https://doi.org/10.5530/ijpi.20260451
Abstract
Background
The 6-Min Walk Distance (6MWD) test is widely used to assess functional capacity in respiratory patients, but response patterns across different respiratory conditions remain poorly understood.
Materials and Methods
115 patients (29 Asthma, 46 COPD, 40 ILD) underwent 6MWD testing before and after pulmonary rehabilitation. Changes in distance, heart rate, and oxygen saturation were analyzed across diagnostic groups.
Results
Mean 6MWD improved from 363.90 m to 375.26 m post-rehabilitation. Asthma patients showed the most significant improvement (30 m increase), followed by COPD (8 m increase), while ILD patients showed minimal change. Heart rate and SpO2 changes during testing showed no significant differences pre- and post-rehabilitation (p>0.05). Diagnostic category significantly influenced improvement patterns (p<0.05).
Conclusion
The effectiveness of pulmonary rehabilitation on functional capacity varies significantly across respiratory conditions, with asthma patients showing the most marked improvements. These findings suggest the need for condition-specific rehabilitation protocols and indicate that 6MWD improvements may not be a universally appropriate primary outcome measure across all respiratory conditions.
Keywords
Subject
Article metadata
| Title | Comparative Analysis of Functional Capacity Improvements Through 6MWD Testing Across Different Respiratory Conditions: Implications for Targeted Pulmonary Rehabilitation |
|---|---|
| Authors | Sneha Chacko; Gaurang Shah |
| Affiliations | Department of Pharmacology L. M. College of Pharmacy, Ahmedabad, Gujarat, INDIA, INDIA. |
| Corresponding author | saumyasneha@gmail.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 16, Issue 1 (2026) |
Also in this issue
- Anti-Parkinson Drug Levodopa: It's Novel Delivery Systems, Preclinical and Clinical Studies: A Reviewpp. 1–11
- Shifting Regulatory Frameworks for Nanomedicine in the Evolution of Personalized Medicinepp. 12–22
- A Global Perspective on Navigating the Regulatory Landscape of Adaptive AI in Healthcare: Balancing Innovation and Patient Safetypp. 23–29
- Impact of Artificial Intelligence Assisted Drug Therapy Optimization on Drug Related Problems Amongst Older Adult Patients: A Systematic Reviewpp. 30–42
- The Empowerment of Drugs Inspectors Under the Drugs and Cosmetics Act, 1940-A Review of Implementation of Power of Arrest Conferred by Hon’ble Supreme Court of Indiapp. 43–50